Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roelof J C Kluin

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
ALTEX|July 6, 2022
Comparison of human recombinant protein coatings and fibroblast-ECM to Matrigel for induced pluripotent stem cell culture and renal podocyte differentiationCormac Murphy, Elisabeth Naderlinger, Amber Mater, et al.
Bioinformatics (Oxford, England)|July 17, 2012
A regression model for estimating DNA copy number applied to capture sequencing dataGuillem J Rigaill, Sidney Cadot, Roelof J C Kluin, et al.
Cancer Research|May 31, 2018
Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell LinesKatarzyna Jastrzebski, Bram Thijssen, Roelof J C Kluin, et al.
Plos One|November 9, 2018
Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint associationDavid M Vossen, Caroline V M Verhagen, Reidar Grénman, et al.
Cancer Cell|January 9, 2024
Distinct spatiotemporal dynamics of CD8<sup>+</sup> T cell-derived cytokines in the tumor microenvironmentMirjam E Hoekstra, Maarten Slagter, Jos Urbanus, et al.
Nature Communications|March 23, 2024
Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinomaChristel F A Ramirez, Daniel Taranto, Masami Ando-Kuri, et al.
British Journal of Cancer|February 6, 2022
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patientsLeonora W de Boo, Katarzyna Jóźwiak, Heikki Joensuu, et al.
The Journal of Pathology|December 5, 2012
An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancerIan J Majewski, Irma Kluijt, Annemieke Cats, et al.
BMC Bioinformatics|October 6, 2018
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence dataRoelof J C Kluin, Kristel Kemper, Thomas Kuilman, et al.
Molecular Oncology|May 26, 2015
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potentialTesa M Severson, Justine Peeters, Ian Majewski, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
ALTEX|July 6, 2022
Comparison of human recombinant protein coatings and fibroblast-ECM to Matrigel for induced pluripotent stem cell culture and renal podocyte differentiationCormac Murphy, Elisabeth Naderlinger, Amber Mater, et al.
Bioinformatics (Oxford, England)|July 17, 2012
A regression model for estimating DNA copy number applied to capture sequencing dataGuillem J Rigaill, Sidney Cadot, Roelof J C Kluin, et al.
Cancer Research|May 31, 2018
Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell LinesKatarzyna Jastrzebski, Bram Thijssen, Roelof J C Kluin, et al.
Plos One|November 9, 2018
Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint associationDavid M Vossen, Caroline V M Verhagen, Reidar Grénman, et al.
Cancer Cell|January 9, 2024
Distinct spatiotemporal dynamics of CD8<sup>+</sup> T cell-derived cytokines in the tumor microenvironmentMirjam E Hoekstra, Maarten Slagter, Jos Urbanus, et al.
Nature Communications|March 23, 2024
Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinomaChristel F A Ramirez, Daniel Taranto, Masami Ando-Kuri, et al.
British Journal of Cancer|February 6, 2022
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patientsLeonora W de Boo, Katarzyna Jóźwiak, Heikki Joensuu, et al.
The Journal of Pathology|December 5, 2012
An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancerIan J Majewski, Irma Kluijt, Annemieke Cats, et al.
BMC Bioinformatics|October 6, 2018
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence dataRoelof J C Kluin, Kristel Kemper, Thomas Kuilman, et al.
Molecular Oncology|May 26, 2015
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potentialTesa M Severson, Justine Peeters, Ian Majewski, et al.
Pageof 3